Transplanted hepatocytes engraft, survive, and proliferate in the liver of rats with carbon tetrachloride-induced cirrhosis

S. Gagandeep, Pankaj Rajvanshi, Rana P. Sokhi, Sanjeev Slehria, Christopher J. Palestro, Kuldeep K. Bhargava, Sanjeev Gupta

Research output: Contribution to journalArticle

55 Citations (Scopus)

Abstract

Repopulation of the cirrhotic liver with disease-resistant hepatocytes could offer novel therapies, as well as systems for biological studies. Establishing whether transplanted hepatocytes can engraft, survive, and proliferate in the cirrhotic liver is a critical demonstration. Dipeptidyl peptidase IV-deficient F344 rats were used to localize transplanted hepatocytes isolated from the liver of syngeneic normal F344 rats. Cirrhosis was induced by administration of carbon tetrachloride with phenobarbitone and these drugs were withdrawn prior to cell transplantation. Cirrhotic rats showed characteristic hepatic histology, as well as significant portosystemic shunting. When hepatocytes were transplanted via the spleen, cells were distributed immediately in periportal areas, fibrous septa, and regenerative nodules of the cirrhotic liver. Although some transplanted cells translocated into pulmonary capillaries, this was not deleterious. At 1 week, transplanted cells were fully integrated in the liver parenchyma, along with expression of glucose-6-phosphatase and glycogen as reporters of hepatic function. Transplanted callose proliferated in the liver of cirrhotic animals and survived indefinitely. At 1 year, transplanted hepatocytes formed large clusters containing several-fold more cells than normal control animals, which was in agreement with increased cell turnover in the cirrhotic rat liver. The findings indicate that the cirrhotic liver can be repopulated with functionally intact hepatocytes that are capable of proliferating. Liver repopulation using disease-resistant hepatocytes will be applicable in chronic conditions, such as viral hepatitis or Wilson's disease. Copyright (C) 2000 John Wiley and Sons, Ltd.

Original languageEnglish (US)
Pages (from-to)78-85
Number of pages8
JournalJournal of Pathology
Volume191
Issue number1
DOIs
StatePublished - May 2000

Fingerprint

Carbon Tetrachloride
Hepatocytes
Fibrosis
Liver
Inbred F344 Rats
Dipeptidyl Peptidase 4
Glucose-6-Phosphatase
Hepatolenticular Degeneration
Cell Transplantation
Virus Diseases
Phenobarbital
Glycogen
Hepatitis
Liver Diseases
Histology
Spleen
Lung

Keywords

  • Cirrhosis
  • Dipeptidyl peptidase IV
  • Gene expression
  • Hepatocyte transplantation
  • Liver
  • Liver regeneration

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Transplanted hepatocytes engraft, survive, and proliferate in the liver of rats with carbon tetrachloride-induced cirrhosis. / Gagandeep, S.; Rajvanshi, Pankaj; Sokhi, Rana P.; Slehria, Sanjeev; Palestro, Christopher J.; Bhargava, Kuldeep K.; Gupta, Sanjeev.

In: Journal of Pathology, Vol. 191, No. 1, 05.2000, p. 78-85.

Research output: Contribution to journalArticle

Gagandeep, S. ; Rajvanshi, Pankaj ; Sokhi, Rana P. ; Slehria, Sanjeev ; Palestro, Christopher J. ; Bhargava, Kuldeep K. ; Gupta, Sanjeev. / Transplanted hepatocytes engraft, survive, and proliferate in the liver of rats with carbon tetrachloride-induced cirrhosis. In: Journal of Pathology. 2000 ; Vol. 191, No. 1. pp. 78-85.
@article{78a98e74716c4a9da78eb23e1369ed56,
title = "Transplanted hepatocytes engraft, survive, and proliferate in the liver of rats with carbon tetrachloride-induced cirrhosis",
abstract = "Repopulation of the cirrhotic liver with disease-resistant hepatocytes could offer novel therapies, as well as systems for biological studies. Establishing whether transplanted hepatocytes can engraft, survive, and proliferate in the cirrhotic liver is a critical demonstration. Dipeptidyl peptidase IV-deficient F344 rats were used to localize transplanted hepatocytes isolated from the liver of syngeneic normal F344 rats. Cirrhosis was induced by administration of carbon tetrachloride with phenobarbitone and these drugs were withdrawn prior to cell transplantation. Cirrhotic rats showed characteristic hepatic histology, as well as significant portosystemic shunting. When hepatocytes were transplanted via the spleen, cells were distributed immediately in periportal areas, fibrous septa, and regenerative nodules of the cirrhotic liver. Although some transplanted cells translocated into pulmonary capillaries, this was not deleterious. At 1 week, transplanted cells were fully integrated in the liver parenchyma, along with expression of glucose-6-phosphatase and glycogen as reporters of hepatic function. Transplanted callose proliferated in the liver of cirrhotic animals and survived indefinitely. At 1 year, transplanted hepatocytes formed large clusters containing several-fold more cells than normal control animals, which was in agreement with increased cell turnover in the cirrhotic rat liver. The findings indicate that the cirrhotic liver can be repopulated with functionally intact hepatocytes that are capable of proliferating. Liver repopulation using disease-resistant hepatocytes will be applicable in chronic conditions, such as viral hepatitis or Wilson's disease. Copyright (C) 2000 John Wiley and Sons, Ltd.",
keywords = "Cirrhosis, Dipeptidyl peptidase IV, Gene expression, Hepatocyte transplantation, Liver, Liver regeneration",
author = "S. Gagandeep and Pankaj Rajvanshi and Sokhi, {Rana P.} and Sanjeev Slehria and Palestro, {Christopher J.} and Bhargava, {Kuldeep K.} and Sanjeev Gupta",
year = "2000",
month = "5",
doi = "10.1002/(SICI)1096-9896(200005)191:1<78::AID-PATH587>3.0.CO;2-P",
language = "English (US)",
volume = "191",
pages = "78--85",
journal = "Journal of Pathology",
issn = "0022-3417",
publisher = "John Wiley and Sons Ltd",
number = "1",

}

TY - JOUR

T1 - Transplanted hepatocytes engraft, survive, and proliferate in the liver of rats with carbon tetrachloride-induced cirrhosis

AU - Gagandeep, S.

AU - Rajvanshi, Pankaj

AU - Sokhi, Rana P.

AU - Slehria, Sanjeev

AU - Palestro, Christopher J.

AU - Bhargava, Kuldeep K.

AU - Gupta, Sanjeev

PY - 2000/5

Y1 - 2000/5

N2 - Repopulation of the cirrhotic liver with disease-resistant hepatocytes could offer novel therapies, as well as systems for biological studies. Establishing whether transplanted hepatocytes can engraft, survive, and proliferate in the cirrhotic liver is a critical demonstration. Dipeptidyl peptidase IV-deficient F344 rats were used to localize transplanted hepatocytes isolated from the liver of syngeneic normal F344 rats. Cirrhosis was induced by administration of carbon tetrachloride with phenobarbitone and these drugs were withdrawn prior to cell transplantation. Cirrhotic rats showed characteristic hepatic histology, as well as significant portosystemic shunting. When hepatocytes were transplanted via the spleen, cells were distributed immediately in periportal areas, fibrous septa, and regenerative nodules of the cirrhotic liver. Although some transplanted cells translocated into pulmonary capillaries, this was not deleterious. At 1 week, transplanted cells were fully integrated in the liver parenchyma, along with expression of glucose-6-phosphatase and glycogen as reporters of hepatic function. Transplanted callose proliferated in the liver of cirrhotic animals and survived indefinitely. At 1 year, transplanted hepatocytes formed large clusters containing several-fold more cells than normal control animals, which was in agreement with increased cell turnover in the cirrhotic rat liver. The findings indicate that the cirrhotic liver can be repopulated with functionally intact hepatocytes that are capable of proliferating. Liver repopulation using disease-resistant hepatocytes will be applicable in chronic conditions, such as viral hepatitis or Wilson's disease. Copyright (C) 2000 John Wiley and Sons, Ltd.

AB - Repopulation of the cirrhotic liver with disease-resistant hepatocytes could offer novel therapies, as well as systems for biological studies. Establishing whether transplanted hepatocytes can engraft, survive, and proliferate in the cirrhotic liver is a critical demonstration. Dipeptidyl peptidase IV-deficient F344 rats were used to localize transplanted hepatocytes isolated from the liver of syngeneic normal F344 rats. Cirrhosis was induced by administration of carbon tetrachloride with phenobarbitone and these drugs were withdrawn prior to cell transplantation. Cirrhotic rats showed characteristic hepatic histology, as well as significant portosystemic shunting. When hepatocytes were transplanted via the spleen, cells were distributed immediately in periportal areas, fibrous septa, and regenerative nodules of the cirrhotic liver. Although some transplanted cells translocated into pulmonary capillaries, this was not deleterious. At 1 week, transplanted cells were fully integrated in the liver parenchyma, along with expression of glucose-6-phosphatase and glycogen as reporters of hepatic function. Transplanted callose proliferated in the liver of cirrhotic animals and survived indefinitely. At 1 year, transplanted hepatocytes formed large clusters containing several-fold more cells than normal control animals, which was in agreement with increased cell turnover in the cirrhotic rat liver. The findings indicate that the cirrhotic liver can be repopulated with functionally intact hepatocytes that are capable of proliferating. Liver repopulation using disease-resistant hepatocytes will be applicable in chronic conditions, such as viral hepatitis or Wilson's disease. Copyright (C) 2000 John Wiley and Sons, Ltd.

KW - Cirrhosis

KW - Dipeptidyl peptidase IV

KW - Gene expression

KW - Hepatocyte transplantation

KW - Liver

KW - Liver regeneration

UR - http://www.scopus.com/inward/record.url?scp=0034012120&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034012120&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1096-9896(200005)191:1<78::AID-PATH587>3.0.CO;2-P

DO - 10.1002/(SICI)1096-9896(200005)191:1<78::AID-PATH587>3.0.CO;2-P

M3 - Article

VL - 191

SP - 78

EP - 85

JO - Journal of Pathology

JF - Journal of Pathology

SN - 0022-3417

IS - 1

ER -